Raiffeisen Bank International AG Purchases Shares of 99,963 Core Laboratories Inc. (NYSE:CLB)

Raiffeisen Bank International AG bought a new position in shares of Core Laboratories Inc. (NYSE:CLB - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 99,963 shares of the oil and gas company's stock, valued at approximately $1,706,000. Raiffeisen Bank International AG owned 0.21% of Core Laboratories as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also recently made changes to their positions in the company. Point72 Asset Management L.P. purchased a new stake in shares of Core Laboratories during the fourth quarter worth approximately $266,000. ProShare Advisors LLC purchased a new stake in shares of Core Laboratories during the fourth quarter worth approximately $245,000. Quantinno Capital Management LP purchased a new stake in shares of Core Laboratories during the fourth quarter worth approximately $195,000. Millennium Management LLC increased its stake in shares of Core Laboratories by 429.0% during the fourth quarter. Millennium Management LLC now owns 65,616 shares of the oil and gas company's stock worth $1,136,000 after buying an additional 53,213 shares during the period. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in shares of Core Laboratories by 3.7% during the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 26,723 shares of the oil and gas company's stock worth $463,000 after buying an additional 960 shares during the period. 97.81% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on the stock. StockNews.com lowered shares of Core Laboratories from a "hold" rating to a "sell" rating in a research note on Friday, April 25th. Stifel Nicolaus dropped their price target on shares of Core Laboratories from $19.00 to $15.00 and set a "hold" rating on the stock in a research note on Tuesday, April 15th. Finally, Citigroup dropped their price target on shares of Core Laboratories from $16.00 to $13.00 and set a "neutral" rating on the stock in a research note on Tuesday, May 13th. Two analysts have rated the stock with a sell rating and three have issued a hold rating to the company's stock. According to data from MarketBeat.com, Core Laboratories currently has an average rating of "Hold" and a consensus target price of $15.00.

Core Laboratories Price Performance

Shares of NYSE CLB traded down $0.24 during trading on Monday, hitting $11.61. 225,035 shares of the company were exchanged, compared to its average volume of 404,467. The company has a market cap of $544.31 million, a price-to-earnings ratio of 17.59, a PEG ratio of 0.99 and a beta of 1.45. Core Laboratories Inc. has a 1 year low of $10.14 and a 1 year high of $25.13. The firm's fifty day moving average price is $12.94 and its 200 day moving average price is $16.39. The company has a debt-to-equity ratio of 0.49, a current ratio of 2.32 and a quick ratio of 1.71.

Core Laboratories (NYSE:CLB - Get Free Report) last issued its earnings results on Wednesday, April 23rd. The oil and gas company reported $0.14 EPS for the quarter, missing the consensus estimate of $0.15 by ($0.01). The company had revenue of $123.59 million for the quarter, compared to analysts' expectations of $125.09 million. Core Laboratories had a return on equity of 16.24% and a net margin of 5.99%. Core Laboratories's revenue for the quarter was down 4.7% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.19 earnings per share. On average, sell-side analysts expect that Core Laboratories Inc. will post 0.96 earnings per share for the current fiscal year.

Core Laboratories Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, May 27th. Stockholders of record on Monday, May 5th will be paid a dividend of $0.01 per share. This represents a $0.04 annualized dividend and a dividend yield of 0.34%. The ex-dividend date is Monday, May 5th. Core Laboratories's dividend payout ratio (DPR) is presently 6.78%.

Core Laboratories Profile

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.